Immune evasion by gamma-herpesviruses

Current Opinion in Immunology

Volumn 16, Issue 4, 2004, Pages 456-462

  Stevenson, Philip G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CTL; cytotoxic T lymphocyte; EBV; endoplasmic reticulum; Epstein Barr virus; ER; IFN; IL; interferon; interleukin; Kaposi's sarcoma associated herpesvirus; KSHV; MHV 68; murine gamma herpesvirus 68; PCR; polymerase chain reaction; TAP

Indexed keywords

HERPES VACCINE; VIRUS PROTEIN;

CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HERPES VIRUS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; REVIEW; VACCINATION; VIRUS ACTIVATION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; VIRUS VIRULENCE;

GAMMAHERPESVIRINAE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VIRAL VACCINES; VIRUS LATENCY; VIRUS REPLICATION;

EID: 3042853050     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.05.002     Document Type: Review

References (49)

1. Keating S., Prince S., Jones M., Rowe M. The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules. J Virol. 76:2002;8179-8188
2. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 375:1995;685-688
3. Yin Y., Manoury B., Fahraeus R. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science. 301:2003;1371-1374 In line with the defective ribosomal products (DRiP) hypothesis of Yewdell, et al. [49], limiting translation is shown to be an essential component of evading antigen presentation.
4. Bridgeman A., Stevenson P.G., Simas J.P., Efstathiou S. A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J Exp Med. 194:2001;301-312
5. Stevenson P.G., May J.S., Smith X.G., Marques S., Adler H., Koszinowski U.H., Simas J.P., Efstathiou S. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol. 3:2002;733-740
6. Coleman H.M., de Lima B., Morton V., Stevenson P.G. Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol. 7:2003;2410-2417
7. Moore P.S., Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol. 57:2003;609-639
8. Ohga S., Nomura A., Takada H., Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol. 44:2002;203-215
9. Blasdell K., McCracken C., Morris A., Nash A.A., Begon M., Bennett M., Stewart J.P. The wood mouse is a natural host for Murid herpesvirus 4. J Gen Virol. 84:2003;111-113
10. Boname J.M., Stevenson P.G. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity. 15:2001;627-636
11. Coscoy L., Sanchez D.J., Ganem D. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J Cell Biol. 155:2001;1265-1273
12. Ishido S., Wang C., Lee B.S., Cohen G.B., Jung J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol. 74:2000;5300-5309
13. Coscoy L., Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA. 97:2000;8051-8056
14. Hewitt E.W., Duncan L., Mufti D., Baker J., Stevenson P.G., Lehner P.J. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J. 21:2002;2418-2429
15. Lorenzo M.E., Jung J.U., Ploegh H.L. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J Virol. 76:2002;5522-5531
16. ••].
17. ••] suggest that viral evasion is only the tip of the iceberg for membrane-bound RING finger E3 ubiquitin-protein ligases. Although all the data so far are based on overexpression, it seems likely that this is a general cellular mechanism of modulating membrane protein expression.
18. Ishido S., Choi J.K., Lee B.S., Wang C., DeMaria M., Johnson R.P., Cohen G.B., Jung J.U. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity. 13:2000;365-374
19. Coscoy L., Ganem D. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest. 107:2001;1599-1606
20. Means R.E., Ishido S., Alvarez X., Jung J.U. Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein. EMBO J. 21:2002;1638-1649
21. Lybarger L., Wang X., Harris M.R., Virgin H.W., Hansen T.H. Virus subversion of the MHC class I peptide-loading complex. Immunity. 18:2003;121-130 The MHV-68 MK3 protein is shown to require the peptide loading complex for stability and to capture MHC class I.
22. Boname J.M., de Lima B., Lehner P.J., Stevenson P.G. Viral degradation of the MHC class I peptide loading complex. Immunity. 20:2004;305-317 The MHV-68 MK3 is shown to degrade TAP as a second mechanism of immune evasion. This provides a plausible rationale for a specific association between MK3 and TAP1.
23. Sarid R., Wiezorek J.S., Moore P.S., Chang Y. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol. 73:1999;1438-1446
24. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J.L., Schroter M., et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:1997;517-521
25. Djerbi M., Screpanti V., Catrina A.I., Bogen B., Biberfeld P., Grandien A. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med. 190:1999;1025-1032
26. Marques S., Efstathiou S., Smith K.G., Haury M., Simas J.P. Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol. 77:2003;7308-7318 The dissection of lymph node populations into those with lytic and latent gene expression suggests how a viral lytic evasion protein, M3, might help to promote latency amplification.
27. Coleman H.M., Brierley I., Stevenson P.G. An internal ribosome entry site directs translation of the murine gammaherpesvirus 68 MK3 open reading frame. J Virol. 77:2003;13093-13105
28. Tomescu C., Law W.K., Kedes D.H. Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J Virol. 77:2003;9669-9684
29. Alexander J.M., Nelson C.A., van Berkel V., Lau E.K., Studts J.M., Brett T.J., Speck S.H., Handel T.M., Virgin H.W., Fremont D.H. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell. 111:2002;343-356
30. van Berkel V., Levine B., Kapadia S.B., Goldman J.E., Speck S.H., Virgin H.W. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J Clin Invest. 109:2002;905-914
31. Rice J., de Lima B., Stevenson F.K., Stevenson P.G. A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope. Eur J Immunol. 32:2002;3481-3487
32. May J.S., Coleman H.M., Smillie B., Efstathiou S., Stevenson P.G. Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol. 85:2004;137-146
33. Salek-Ardakani S., Arrand J.R., Mackett M. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology. 304:2002;342-351
34. Lindow M., Nansen A., Bartholdy C., Stryhn A., Hansen N.J., Boesen T.P., Wells T.N., Schwartz T.W., Thomsen A.R. The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation. J Virol. 77:2003;7393-7400
35. Tripp R.A., Hamilton-Easton A.M., Cardin R.D., Nguyen P., Behm F.G., Woodland D.L., Doherty P.C., Blackman M.A. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen? J Exp Med. 185:1997;1641-1650
36. Cardin R.D., Brooks J.W., Sarawar S.R., Doherty P.C. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med. 184:1996;863-871
37. Tibbetts S.A., van Dyk L.F., Speck S.H., Virgin H.W. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol. 76:2002;7125-7132
38. Stevenson P.G., Cardin R.D., Christensen J.P., Doherty P.C. Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol. 80:1999;477-483
39. Stewart J.P., Micali N., Usherwood E.J., Bonina L., Nash A.A. Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination. Vaccine. 17:1999;152-157
40. Stevenson P.G., Belz G.T., Castrucci M.R., Altman J.D., Doherty P.C. A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci USA. 96:1999;9281-9286
41. Usherwood E.J., Ward K.A., Blackman M.A., Stewart J.P., Woodland D.L. Latent antigen vaccination in a model gammaherpesvirus infection. J Virol. 75:2001;8283-8288
42. Tibbetts S.A., McClellan J.S., Gangappa S., Speck S.H., Virgin H.W. Effective vaccination against long-term gammaherpesvirus latency. J Virol. 77:2003;2522-2529 A demonstration, counter to several case reports of co-infection by multiple herpesviruses, that when a herpesvirus has established latency, subsequent infections by the same virus are severely attenuated.
43. ••].
44. ••] demonstrate the surprising effectiveness of latency-deficient mutants in protection against host colonisation by wild-type MHV-68. This proof of principle suggests a general strategy for effective gamma-herpesvirus vaccination.
45. Ressing M.E., van Leeuwen D., Verreck F.A., Gomez R., Heemskerk B., Toebes M., Mullen M.M., Jardetzky T.S., Longnecker R., Schilham M.W., et al. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc Natl Acad Sci USA. 100:2003;11583-11588
46. + T cells may be the key to controlling EBV.
47. Christensen J.P., Cardin R.D., Branum K.C., Doherty P.C. CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma. Proc Natl Acad Sci USA. 96:1999;5135-5140
48. Weck K.E., Dal Canto A.J., Gould J.D., O'Guin A.K., Roth K.A., Saffitz J.E., Speck S.H., Virgin H.W. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med. 3:1997;1346-1353
49. Yewdell J.W., Reits E., Neefjes J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol. 3:2003;952-961